What Is The Long-Term Forecast For The Global Prostate Health Market Growing At 9.1% CAGR?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Prostate Health Industry By 2029?
The market size for prostate health has significantly expanded in the past few years. It is projected to escalate from $34.07 billion in 2024 to $37.23 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 9.3%. The historic surge has been driven by factors such as an aging population, increased PSA screening, heightened awareness programs, developments in hormone therapy, and a rise in incidence rates.
The size of the prostate health market is projected to significantly increase in the coming years, achieving a value of $52.81 billion in 2029 with a compound annual growth rate (CAGR) of 9.1%. Projected growth during the forecast period is due to factors like the increasing utilization of precision medicine, the surge in AI-driven diagnoses, the broadening of targeted radiotherapy applications, increased preference for minimum invasive therapies and advancements in genetic profiling for risk evaluation. Prominent trends for the period forecasted involve AI-enhanced risk evaluation, progress in liquid biopsy, the emergence of next-gen radiotheranostics, revolutionary developments in immunotherapy, and real-time monitoring of biomarkers.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp
Which Factors Are Steering Growth In The Prostate Health Market?
The prostate health market is projected to expand due to the increasing incidence of prostate cancer. Prostate cancer, a disease characterized by the uncontrolled growth of cells in the prostate gland, often presents itself as adenocarcinomas, which are the prevalent form of this ailment among males. The surge in prostate cancer cases mainly arises from the aging population, enhanced screening procedures, and lifestyle influences such as obesity and lack of physical activity. The importance of prostate health is emphasized in the prevention, early diagnosis, and treatment of prostate cancer. As noted by the American Cancer Society (ACS), a non-profit organization based in the US, around 288,300 new diagnoses of prostate cancer were expected for January 2023 in the United States, with approximately 34,700 projected fatalities from the disease. Thus, the growth of the prostate health market is anticipated due to the increasing incidence of prostate cancer.
Which Segment Accounts For The Largest Share In The Prostate Health Market?
The prostate healthmarket covered in this report is segmented –
1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer; Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH; Moderate BPH; Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis; Chronic Bacterial Prostatitis; Chronic Prostatitis (Non-Bacterial)
What Strategic Shifts And Innovations Are Influencing The Prostate Health Market?
Leading companies in the prostate health market are prioritizing technological innovations like AI-driven risk assessment to strengthen their competitive position. This AI-powered risk assessment employs artificial intelligence algorithms to evaluate data and forecast potential risks, facilitating informed decision-making and enhancing patient outcomes. For example, in September 2024, Nanostics Inc., a Canadian clinical-stage biotech firm, teamed up with US-based Protean BioDiagnostics to introduce CDX Prostate, a diagnostic tool targeted at men at risk of aggressive prostate cancer. This tool integrates biological data, clinical insights, and AI-driven learning models to produce a risk score for aggressive prostate cancer. By leveraging sophisticated machine learning algorithms to analyze diverse biological and clinical information, CDX Prostate offers a more precise risk score compared to traditional approaches. This test assists healthcare providers and patients in deciding whether to proceed with a biopsy following a high prostate-specific antigen (PSA) result or an abnormal digital rectal exam (DRE).
Who Are The Dominant Players In The Prostate Health Market Today?
Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report
What Regional Factors Are Accelerating Growth In The Prostate Health Market?
North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21265&type=smp
Browse Through More Reports Similar to the Global Prostate Health Market 2025, By The Business Research Company
Healthcare Ecommerce Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report
Other Health And Personal Care Stores Global Market Report 2025
Residential Substance Abuse And Mental Health Facilities Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
